Regencell Bioscience
RGC
#9037
Rank
NZ$0.12 B
Marketcap
$9.67
Share price
-0.88%
Change (1 day)
-49.08%
Change (1 year)

Regencell Bioscience (RGC) - Cash on Hand

Cash on Hand as of June 2024 : NZ$13.62 Million

According to Regencell Bioscience's latest financial reports the company has NZ$13.62 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regencell Bioscience - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30NZ$19.06 M-27.72%
2022-06-30NZ$26.37 M30926.35%
2021-06-30NZ$0.08 M-85.88%
2020-06-30NZ$0.6 M66.34%
2019-06-30NZ$0.36 M